Protagonist Therapeutics, Inc. · NASDAQ:PTGX
Vanguard Capital Management LLC reported a 5.09% stake in Protagonist Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 30, 2026
Vanguard Capital Management LLC reported a 5.09% stake in Protagonist Therapeutics, Inc., 3,250,003 shares, as a passive investor on Mar 31, 2026. Filed Apr 30, 2026 (Schedule 13G).
- Stake
- 5.09%
- Shares
- 3,250,003
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.09% | 3,250,003 |
Source
Related
- Protagonist Therapeutics, Inc.
- Vanguard Capital Management LLC
- Protagonist Therapeutics, Inc. shareholders
- Form 4 · Ali Asif · Oct 2, 2026
- Form 4 · Patel Dinesh V Ph D · Sep 10, 2026
- Form 4 · Patel Dinesh V Ph D · Sep 8, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 13, 2026
- Form 4 · Patel Dinesh V Ph D · Aug 12, 2026